Categories AlphaGraphs, Earnings, Retail

Lowe’s stock falls on comp sales miss

Lowe’s Companies Inc. (LOW) beat market estimates on sales and EPS for the second quarter of 2018 but comp sales missed the mark, sending shares down over 4% during premarket hours.

Lowe’s reported a 7.1% increase in sales to $20.9 billion from the same period last year. Comparable sales grew 5.2% while comp sales for the US home improvement business rose 5.3%.

Net income improved to $1.5 billion or $1.86 per diluted share from $1.4 billion or $1.68 per diluted share in the prior-year period. Adjusted EPS increased 31.8% to $2.07.

For fiscal year 2018, Lowe’s expects total sales to increase about 4.5% and comparable sales to increase around 3%. Diluted EPS is expected to be $4.50 to $4.60.

Lowe's second quarter 2018 earnings
Lowe’s Companies Q2 2018 Earnings Infographic

Lowe’s has decided to exit its Orchard Supply Hardware business so that it can focus on its core home improvement operations. The company plans to close all 99 Orchard Supply Hardware stores in California, Oregon and Florida, as well as its distribution facility by the end of fiscal 2018. Lowe’s has partnered with Hilco Merchant Services to manage the process systematically.

The retailer expects to incur additional pretax costs of $390 million to $475 million associated with this in the second half of 2018.

Lowe’s had 2,155 home improvement and hardware stores in the US, Canada and Mexico as of August 3. The company plans to add around nine home improvement stores in 2018.

Last week, Lowe’s rival Home Depot (HD) reported quarterly results that beat expectations and lifted the stock. Home Depot’s comp sales rose 8% for its second quarter.

Related: Lowe’s Q2 2018 Earnings Transcript

Related: Lowe’s Q2 2018 Earnings Preview

Related: Lowe’s Q1 2018 Earnings Infographic

Lowe's first quarter 2018 earnings

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top